Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity

PLEVOVÁ, Karla, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Eva DIVÍŠKOVÁ, Jana KOTAŠKOVÁ, Martin TRBUŠEK, Yvona BRYCHTOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity. In 2nd Interantional Conference on New Concepts in B-cell malignancies. 2016.

Basic information

Original name

Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity

Authors

PLEVOVÁ, Karla, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Eva DIVÍŠKOVÁ, Jana KOTAŠKOVÁ, Martin TRBUŠEK, Yvona BRYCHTOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ

Edition

2nd Interantional Conference on New Concepts in B-cell malignancies, 2016

---

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology

---

Links

LQ1601, research and development project	Name: CEITEC 2020 (Acronym: CEITEC2020) Investor: Ministry of Education, Youth and Sports of the CR
15-31834A, interní kód MU (CEP code: NV15-31834A)	Name: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie Investor: Ministry of Health of the CR
692298, interní kód MU	Name: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET) Investor: European Union, Spreading excellence and widening participation